Packaging & Paper Global On demand · 24-48h

Global Tubular Glass Injection Vials Market Strategic Research Report

Global Tubular Glass Injection Vials Market Strategic Resear…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Tubular Glass Injection Vials Market
$3.29B2025
5.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Soda-lime Glass, Low Borosilicate Glass, Medium Borosilicate Glass, High Borosilicate Glass

By Application: Biologicals, Lyophilized Powder Injection, Vaccines, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: SGD, SCHOTT Pharma, Gerresheimer AG, DWK Life Sciences, Stevanato Group, Corning, Nipro Corporation, Daikyo Seiko, West Pharmaceutical, Radpharm Scientific, Pacific Vial Manufacturing, Ningbo Zhengli Pharmaceutical Packaging, Linuo Pharmaceutical Packaging, Chongqing Zhengchuan Pharmaceutical Packaging, Shandong Pharmaceutical Glass, CANGZHOU FOUR STARS GLASS, Anhui Huaxin Pharmaceutical Glass Products, Jiyuan Zhengyu Industrial, Taian Youlyy Industrial, Nantong Xinde Medical Packing Material, Chengdu Jingu Medicinal Packing

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 157 pages
Market size 2025
$3.29B
Billion USD
Forecast CAGR
5.5%
2025-2032
Forecast 2032
$4.8B
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Tubular Glass Injection Vials market size is predicted to grow from US$ 3,285 million in 2025 to US$ 4,776 million in 2032; it is expected to grow at a CAGR of 5.5% from 2026 to 2032.

A tubular glass injection vials is a primary packaging container for injections made from medicinal borosilicate glass tubes or sodium calcium glass tubes through processes such as tube cutting, flame softening, bottle mouth molding, bottle bottom molding, annealing, online detection, cleaning, and clean packaging. It is mainly used for packaging water injections, freeze-dried powder injections, biologics, vaccines, antibody drugs, oncology drugs, anesthetics, diagnostic reagents, and high-end generic drugs. Compared with molded glass injection bottles, tubular glass injection bottles have the characteristics of uniform wall thickness, high dimensional accuracy, good consistency of bottle mouth, high transparency, stable appearance quality, adaptability to high-speed filling lines, and obvious advantages in small capacity specifications. Common specifications include 2ml, 5ml, 7ml, 10ml, 15ml, 20ml, and 30ml. In 2025, global Tubular Glass Injection Vials production reached approximately 57,896 M Units, with an average global market price of around US$ 58 per k unit.

The core change in the tubular glass injection vials market lies in the gradual shift of product attributes from ordinary pharmaceutical packaging materials and consumables to high reliability injection quality system components. Injections that directly enter human blood or tissue require significantly higher chemical stability, water resistance, internal surface precipitation, particle control, bottle mouth size accuracy, sealing consistency, and sterilization adaptability than ordinary oral drug packaging. Therefore, there is still room for improvement in the market penetration rate of high-quality borosilicate tubular glass injection bottles. Global pharmaceutical companies continue to invest in the fields of biologics, vaccines, freeze-dried formulations, cancer treatment drugs, and high-end generic drugs, promoting packaging suppliers to extend from simple bottle supply to clean packaging, ready to use supply, automated full inspection, low precipitation surface control, and long-term quality traceability solutions.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Tubular Glass Injection Vials market?

What factors are driving Tubular Glass Injection Vials market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Tubular Glass Injection Vials market opportunities vary by end market size?

How does Tubular Glass Injection Vials break out by Type, by Application?

This report presents a comprehensive overview of the global Tubular Glass Injection Vials market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Soda-lime Glass
  • Low Borosilicate Glass
  • Medium Borosilicate Glass
  • High Borosilicate Glass

Segment by Appearance

  • Transparent Glass
  • Brown Glass

Segment by Capacity

  • Capacity≤10ml
  • Capacity 10-30ml
  • Capacity≥30ml

Segment by Application

  • Biologicals
  • Lyophilized Powder Injection
  • Vaccines
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Tubular Glass Injection Vials market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Biologicals, Lyophilized Powder Injection, Vaccines evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Tubular Glass Injection Vials Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$3.29B
2025
Forecast
$4.8B
2032
CAGR
5.5%
2025–2032
Gebieden
5
global
Key companies
SGDSCHOTT PharmaGerresheimer AGDWK Life SciencesStevanato GroupCorningNipro CorporationDaikyo Seiko
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Soda-lime GlassLow Borosilicate GlassMedium Borosilicate GlassHigh Borosilicate Glass
By Application
BiologicalsLyophilized Powder InjectionVaccinesOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Soda-lime Glass
  • 3.1.3 Low Borosilicate Glass
  • 3.1.4 Medium Borosilicate Glass
  • 3.1.5 High Borosilicate Glass
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Biologicals
  • 4.1.3 Lyophilized Powder Injection
  • 4.1.4 Vaccines
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 SGD
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 SCHOTT Pharma
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Gerresheimer AG
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 DWK Life Sciences
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Stevanato Group
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Corning
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Nipro Corporation
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Daikyo Seiko
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 West Pharmaceutical
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Radpharm Scientific
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Pacific Vial Manufacturing
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Ningbo Zhengli Pharmaceutical Packaging
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Linuo Pharmaceutical Packaging
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Chongqing Zhengchuan Pharmaceutical Packaging
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Shandong Pharmaceutical Glass
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 CANGZHOU FOUR STARS GLASS
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Anhui Huaxin Pharmaceutical Glass Products
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Jiyuan Zhengyu Industrial
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Taian Youlyy Industrial
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Nantong Xinde Medical Packing Material
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Chengdu Jingu Medicinal Packing
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Tubular Glass Injection Vials market size?
The global Tubular Glass Injection Vials market is estimated at US$ 3.29 billion in 2025 (base year) and is projected to reach US$ 4.78 billion by 2032.
What growth rate is expected for the Tubular Glass Injection Vials market through 2032?
The market is expected to grow at a CAGR of 5.5% from 2026 to 2032, expanding from US$ 3.29 billion in 2025 to US$ 4.78 billion in 2032, roughly 1.5 times its base-year value.
How is Tubular Glass Injection Vials defined?
A tubular glass injection vials is a primary packaging container for injections made from medicinal borosilicate glass tubes or sodium calcium glass tubes through processes such as tube cutting, flame softening, bottle mouth molding, bottle bottom molding, annealing, online detection, cleaning, and clean packaging. It is mainly used for packaging water injections, freeze-dried powder injections, biologics, vaccines, antibody drugs, oncology drugs, anesthetics, diagnostic reagents, and high-end generic drugs.
What are the main segments of the Tubular Glass Injection Vials market by type?
By type, the market is segmented into Soda-lime Glass, Low Borosilicate Glass, Medium Borosilicate Glass and High Borosilicate Glass.
Which applications drive demand in the Tubular Glass Injection Vials market?
Key applications covered include Biologicals, Lyophilized Powder Injection, Vaccines and Other.
Who are the key players in the Tubular Glass Injection Vials market?
Key players profiled include SGD, SCHOTT Pharma, Gerresheimer AG, DWK Life Sciences, Stevanato Group, Corning, Nipro Corporation and Daikyo Seiko, among 21 companies covered in total.
Which regions and countries are covered for Tubular Glass Injection Vials?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Tubular Glass Injection Vials market?
What factors are driving Tubular Glass Injection Vials market growth, globally and by region?
Who should buy the Tubular Glass Injection Vials market report?
The report is intended for manufacturers and solution providers, distributors and end users in Biologicals, Lyophilized Powder Injection and Vaccines, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Tubular Glass Injection Vials market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600